Maria Sharapova Calls Emergency Press Conference to Deliver Critical Career Announcement
Some news to shake up the tennis world.
Speculation that Maria Sharapova would announce her retirement arose when the 28-year-old tennis star called a press conference on Monday, Mar. 7 after dropping out from this week’s BNP Paribas Open. Instead, Sharapova revealed that she tested positive in a drug test during the 2016 Australian Open in January.
“I wanted to let you know that, a few days ago, I received a letter from the ITF that I had failed a drug test at the Australian Open,” Sharapova announced . “I did fail the test and I take full responsibility for it. “For the past 10 years I have been given a medicine called Mildronats by my doctor–by my family doctor–and after I got the letter from ITF I found out it also has another name, of meldonium.”
Meldonium is not approved by the FDA and has recently been added to the International Tennis Federation’s banned substance list due to its performance enhancing properties. However, it is commonly used in Sharapova’s native Russia as an antidote for heart disease.
The New York Times reports that Sharapova is the seventh athlete to test positive for meldonium this year.